Basilea starts second Phase I BAL30072 trial
The trial is aimed to investigate the safety, pharmacokinetics and tolerability of BAL30072 following multiple ascending intravenous infusions in healthy volunteers. BAL30072 demonstrated safety and tolerability profile in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.